Considering that the model showed an AUC of 0.70 with moderate sensitivity and specificity, the result suggests a potential role of serum G6PD activity as a biomarker for gastric cancer stage, but the predictive performance is limited for immediate clinical application. This evidence concerns the gene G6PD and gastric cancer.